Zacks Investment Research | Dec 26, 2018 08:47PM ET
Shares of Perrigo Company plc (NYSE:PRGO) rallied 11.5% on Dec 26 as the deadline to appeal against the tax bill of $1.9 billion from Ireland government approaches. Investors’ sentiment was positive and they expect Perrigo to remain committed to its statement about filing an appeal with the Irish revenue department.
Last week, Perrigo received a notice from the Irish government which held Elan Pharma, a subsidiary of Perrigo, liable to pay the said tax amount related to its sale of Tysabri intellectual property and related assets to Biogen (NASDAQ:BIIB) in 2013. Elan was eligible to receive an upfront payment and future contingent payments from Biogen, which were recognized as trading income, attracting a tax rate of 12.5%.
However, the Irish revenue department stated in the notice that the sale related to Tysabri should be considered as chargeable gains subject to a higher tax rate of 33%. This led to a massive tax bill for Perrigo.
The company’s stock had plunged nearly 30% last week, following the announcement of the tax bill notice in a SEC filing.
Perrigo’s shares are down 53.3% so far this year compared with the industry ’s decline of 11.5%.
In its SEC filing, the company stated that it is on track to file an appeal and expects the proceedings to continue over a period of a few years before completion. Moreover, per the filing, no payment related to tax bill is required until all proceedings are complete.
Perrigo strongly disagreed with the assessment by the Irish revenue department, which neither provided a detailed clarification nor furnished additional documents in support of the bill.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.